Partners
With support
Organizational partners
With information support
Intellectual Partners in Medical Science
Forum business program partners
Forum partners
Digital partner
The State Scientific Center of the Russian Federation "Russian Scientific Center for Surgery named after Academician B. V. Petrovsky"
The State Scientific Center of the Russian Federation "Russian Scientific Center for Surgery named after Academician B. V. Petrovsky" (hereinafter – Center, RSCS) is a federal scientific, clinical and educational center, the largest medical subsidiary institution of the Ministry of Higher Education and Science of the Russian Federation.
The Center combines clinical practice, fundamental and applied scientific researches, educational activities, the unique experience of the Russian surgical school and the most modern approaches, methods and technologies. The RSCS participates in the three national priority projects implementation.
RSCS named after Academician B.V. Petrovsky is one of the leading institutions in Russia for the development and application of innovative technologies in the field of clinical medicine and health sciences. The structure of the Center makes it possible to provide new technologies and medical products for Russian science (from idea to implementation into practice), and for the patient - a full cycle of medical care (from diagnosis and treatment to rehabilitation and full recovery). Educational activities include all stages of personnel training: from career guidance to specialization, residency, postgraduate and doctoral studies.
Our goal is to preserve and improve human health, to develop healthcare, medical science and innovative technologies and to train highly qualified scientific and medical personnel.
FMBA of Russia is a federal executive body that performs the functions of legal regulation in the field of medical and sanitary support for employees of certain sectors of the economy with especially dangerous working conditions, organization of medical and biological support for athletes of sports teams, provision of public services and management of state property in health care, including the provision of medical care, the organization of the activities of the blood service, federal state control (supervision) over ensuring the safety of donor blood and its components, the implementation of federal state sanitary and epidemiological control (supervision) in organizations of certain industries and in certain territories of the Russian Federation, including at the facilities and territories of ZATOs, including the functions of providing medical and sanitary support to employees of organizations and the population of the served territories and organizing medical and social examination of employees of organizations and the population of the served territories.
Center for Strategic Initiatives of FMBA (Autonomous Non-Profit Organization Center for Strategic Initiatives of FMBA)
The Autonomous Non-Profit Organization Center for Strategic Initiatives of FMBA was formed under the aegis of the Federal Medical Biological agency in 2021. The Center is engaged in distribution and promotion of innovation tehnology and pharmaceutical products developed by the network of institutions of the FMBA of Russia.
Full-scale campaign of Center for Strategic Initiatives of FMBA is aimed to optimizing and modernizing processes in the healthcare area and medical tehnology, in particular to implementing healthcare digitalization projects.
NexTouch
NexTouch – is the leading Russian manufacturer of displays, interactive equipment, computing hardware and software solutions, including for educational and inclusive learning purposes.
NexTouch has been recognized as the top brand in the country. President of Russia Vladimir Putin has congratulated the company on its achievement, as well as on winning prestigious awards such as ""Best Industrial Design in Russia"" and ""Brand of the Year in Russia"".
The company operates a full production cycle, with a localization rate exceeding 80%, and manufactures over 45 different types of electronic devices, including displays, interactive panels, all-in-one computers, interactive tables for kids, professional screens, transparent displays, projection equipment, video conferencing systems, motherboards based on domestic processors and more.
These products are used in schools, universities, medical facilities, transportation, industry and other keys sectors of the economy.
Swixx Healthcare LLC
Swixx BioPharma was founded to fully replace biopharma, OTC and medical device multinationals’ subsidiaries or business units in those countries, or therapeutic areas of CEE and beyond, that the multinational biopharma chooses not to enter, or to exit. With its expansion, Swixx BioPharma evolved into a professional and reliable partner with the highest standards in the areas where we operate.
At Swixx, we believe that everyone deserves access to the best medical solutions to live healthier and better lives. Although we are a pharmaceutical company without our own portfolio and research and development (R&D), we are committed to pursuing the standards and culture of a multinational pharmaceutical company.
We are highly experienced professionals, and our background is our strength. We joined forces and use our knowledge to constantly live up to our mission of providing access to the modern medicines of our partners.
For more information about Swixx, please visit: www.swixxbiopharma.com
Swixx Healthcare LLC
9, Zemlyanoj val
Moscow, 105064, Russian Federation
Phone +7 495 229 06 61
E-mail: russia.info@swixxbiopharma.com
Association of Medical Specialists on Risk Modification (AMSRM)
The Association of Medical Specialists for Risk Modification was established in 2021 to attract the attention of the medical community and the general public to solving the problems of managing modifiable risk factors in order to prevent, effective primary and secondary prevention, treatment and rehabilitation of chronic non-communicable diseases, other syndromes, conditions and injuries leading to a loss of autonomy, a decrease in the quality and life expectancy of citizens. The focus of the Association's activities is the development and implementation at the federal level of programs for the comprehensive improvement of the quality of life of patients through the modification of risk factors and the creation of long-term motivation to change consumer behavior. The Association strive to organize a dialogue between all participants in the risk modification process - regulators, doctors, patients, social workers, business representatives.
The BSS holding company is one of the Top-5 medical holdings in the country, is the largest industry holding in the North-Western part of Russia, and has the status of a systemically important enterprise at the federal level. The company was founded in 1996, has a head office in St. Petersburg, and 77 divisions in various regions of the Russian Federation. The holding's assets include pharmaceutical warehouse complexes, a distribution network, a department for working with government orders, the “Aloe” federal pharmacy chain, and medical clinics. Since 2022, the BSS holding has been implementing a vertical integration strategy with a focus on the production of high-tech medical products. In 2024, the company launched Russia's largest production of endoprostheses for large joints and a design office, which is engaged in the development and testing of new designs and production technologies for various products for traumatology and orthopedics.
Velpharm group
Velpharm Group is a pharmaceutical holding whose development strategy is to create a modern business ecosystem for the full-cycle production of medicinal products.
Velpharm Group consists of several companies, the activity of each is aimed at implementing the overall strategy of the Holding, including 3 production sites:
Velpharm - a pharmaceutical plant for the production of finished drugs in a full cycle:
- production of finished drugs (Kurgan)
- production of pharmaceutical substances (Kurgan, Dolgoprudny)
Velpharm-M - a new research and production complex for the development and production of medicines, which owns its own R&D center (Moscow).
Today, Velpharm Group produces more than 120 socially significant drugs of various dosage forms and different therapeutic categories, more than 70 drugs are at different stages of development and registration.
Mission: working to preserve health and quality of people`s lives by creating modern, effective, safe and affordable medicines.
JSC Altayvitaminy
JSC Altayvitaminy is one of the largest pharmaceutical companies in the Russian Federation, which has been developing and producing medicines, medical products, dietary supplements, cosmetics and functional food products since 1949. Today, the company's product range includes more than 170 products.
The company's activities are organized according to the quality management system that meets international standards ISO 9001:2015, including HACCP requirements, and also meets GMP standards for the production and management systems of a pharmaceutical enterprise.
The company has 21 packaging lines for the release of products in various forms: aerosols and sprays, ointments, dragees, tablets and capsules, oils and suppositories, infusions, cosmetics, jelly and drinks. The plant uses modern BOV technology to fill aerosol cans, which maintains the safety and high quality of the product. The company JSC "Altayvitaminy" combines many years of experience and the latest technologies to maintain people's health - the only highest value!
First Line. Health Care Resort
The First Line. Health Care Resort is an innovative resort on the shore of the Gulf of Finland, where the Leaders of the future are taught to manage health and age. Biohacking, doctors as mentors, cellular renewal, biological age determination, VR technologies and modern art - you will immerse yourself in the world of medicine of the future and self-care. At the resort, modern methods of wellness are combined with a wellness environment and premium service.Most suitable wellness program will be selected based on your request: prolongation of youth and weight loss, renewal at the cellular level, recovery of mental well-being. This year, the First Line turned 6 years old. More than 20,000 people have already changed their lives with us! Become visionary about your health at the First-line preventive resort!
Beauty bite
"Beauty bite is the first brand of keto,low-carb and functional food and supplements with a focus on women's healthy lifestyle in the world.
Beauty Bite produces a wide range of world-class food products, ultra-low carbohydrates, without sugar, lactose, or artificial additives"
Innovative clinic of adaptation medicine X-Clinic
X-Clinic is an innovative clinic of adaptation medicine in the Kurortny district of St. Petersburg.
The guests have access to comprehensive recovery programs, more than 1000 outpatient services, including check-up, the latest medical equipment of Russian and foreign production, 75 comfortable lodging rooms, X-Clinic SPA of 1000 sq. meters.
X-Clinic programs are based on proven and effective methods and are aimed at restoring and supporting maximum life potential at physical and psycho-emotional levels. Specialists apply neurophysiological studies and procedures, including neuroenergometry, functional 3D brain mapping, bioacoustic correction, electroson therapy, transcranial electrical stimulation, and audiovisual stimulation.
X-Clinic considers the human body as a single unique system. This allows for highly accurate personalized diagnostics of the state of health, individual treatment programs and recommendations on preventing pathological changes and improving the quality of life.
Skolkovo (VEB.RF Group)
Skolkovo (VEB.RF Group) is the biggest innovation center in Russia. It plays a prominent role in strengthening the foundation of the national economy. Startups promoted by Skolkovo offer domestic hi-tech products for industrial applications, health care, transport industry, IT and many other industries. Skolkovo’s residents well known both in Russia and abroad include: ExoAtlet, Rapidbio, Motorika, Whoosh, Stereotech, OVISION, Yablochkov and many other.
Skolkovo ecosystem is a suite of specialized customer-centered services and relevant support measures for innovative industries: from acceleration and support programs from private investors and university-based startups, to overseas patenting and customs clearance for export/import operations. In 2023, the total revenues of Skolkovo residents grew by 43%, as compared with 2022, reaching RUB 508 billion. As of March 1, 2024, the number of Skolkovo startups exceeded 4,000. The number of jobs within the ecosystem reached 95,000.
PJSC Sovcombank
PJSC Sovcombank — Russian fast growing universal bank with total assets of 1,9 trln rubles — #3 privately-owned bank in Russia by total assets . Sovcombank is designated a systemically important credit institution by the Central Bank of Russia. With more than 2,600 offices, Sovcombank operates one of the largest (#3) retail distribution networks in Russia. Bank has vast experience and expertise in corporate and investment banking and long track-record of successful M&A deals on Russian financial market. Also Bank is the issuer of «Halva» card that is the first installment card on Russian credit card market with more than 9,5 mln cardholders and 250 000 accredited merchants in partnership network. Credit ratings by national scale ACRA — «AA-», «stable», «RAEX» — «ruАA», «stable», «NCR» — «АА-», «positive».
JSC BARS Group
JSC BARS Group is a russian expert and developer of digital solutions for the state, business and individuals with a 30-year history and a staff of more than 2,500 employees. 25 company offices are located in the largest scientific and economic centers of Russia, including Kazan, Moscow, St. Petersburg, Novosibirsk, Kaliningrad, Vladivostok and others. BARS Group takes an active part in the development of the Digital Economy of Russia and creates digital solutions for the implementation of national projects, as well as in import substitution of software - 88 solutions are registered in a software register. All products of a BARS Group is carried out on its own digital platforms and components (BarsUp, Alpha BI, VODY, NXT Core, etc.), which are 100% russian developments. A wide range of both personal design services and application solutions has been created.
R-Pharm Group introduces comprehensive solutions for the healthcare system and focuses on research, development, manufacturing and commercialization of pharmaceuticals, laboratory equipment and medical devices. R-Pharm's mission is to increase the accessibility of advanced diagnostics, preventative care and therapy methods in Russia and abroad.
R-Pharm’s 11 state-of-the-art manufacturing sites are functioning in accordance with international quality standards. The group has signed agreements on strategic partnership, production localization and technology transfer with the world's leading manufacturers of pharmaceuticals and medical equipment.
The most important activities of the group include research and development. Today, R-Pharm’s research pipeline contains more than 100 knowledge-intensive products, many of which are capable of making a serious contribution to the fight against high burden diseases.
JSC GENERIUM
GENERIUM is a full-cycle innovative high-end pharmaceutical company. We are the leader in Russian orphan pharmaceutical market.
GENERIUM possesses its own R&D park, which is capable to handle the full cycle of development of any biological drug, from molecule design to commercial production. We are collaborating in science with leading biotechnological companies and institutes from all over the world.
GENERIUMs manufacturing facilities are equipped with high-end equipment. The work is organized under GMP standards and our plants are ready to produce any kind of biological drugs or ATMPs.
Our mission – our ideas to save life and health.
Ozon Pharmaceuticals
The history of the company begins in 2001. Then the construction of the first production site began, and already in 2003 there were first sales. During this time (21 years), we have become a leading federal pharmaceutical group, which makes a significant contribution to providing the population with affordable medicines and developing import substitution for the entire industry. We currently employ more than 2,500 people in our Group; this is a highly qualified and close-knit team of managers and specialists.
Every 20th package sold in a pharmacy is made by us. We confidently occupy 2nd place in terms of sales in volume terms among all Russian drug manufacturers. Over the past year, we sold more than 285 million packages and reached more than 65 thousand pharmacies throughout the country.
We currently have 16 modern production sites certified according to GMP standards. And we have significant potential to increase production volumes.
We also invest in modern and knowledge-intensive production.
We focus on the safety and availability of our drugs, so we have given preference to working with generics and biosimilars. We do not produce original drugs and do not incur such large costs for R&D and marketing. Thus, due to their cost-effectiveness, analogue molecules are more accessible to patients compared to original molecules.
The example of Ozon Pharmaceuticals shows that Russian companies are capable of developing high-tech enterprises from scratch and bringing them to the international level in the most advanced and competitive areas of human activity.
GEROPHARM
GEROPHARM is an international biotechnological company with all insulin blockbusters in portfolio.
The company is engaged in the full cycle production of medicines, invests in technological development and the creation of modern pharmaceutical infrastructure.
The company possesses an R&D center, as well as two manufacturing sites of API production and production of finished dosage forms.
The company's portfolio includes original drugs and generics in the areas of neurology, ophthalmology, gynecology and urology, as well as 12 medicines in the area of endocrinology - insulins and hypoglycemic drugs. In 2023 GEROPHARM registered a new drug Semavic® which is the first Russian analogue of Ozempic® that is not supplied to Russia anymore.
Today GEROPHARM is a leader in the Russian insulin market in the areas of its presence.
The company's products are presented not only in Russia, but also in 13 countries of the near and far abroad.
НМИЦ Радиологии
FSBI NMRRC of the Ministry of Health of the Russian Federation today is one of the largest oncological and radiological clusters in Russia, the leading institution in radiology, a reference center in the field of pathomorphological research and radiation diagnostics and therapy. Since 2020 it is also the base organization of the CIS member states in the field of oncology.
Two national registers operate on the basis of National Medical Research Center of Radiology of the Ministry of Health of Russia: Cancer - register and the National Radiation - Epidemiological Register.
The Center has a full range of modern diagnostics and complex and combined methods of treatment of cancer patients. The center has in its arsenal all types of modern beam installations, including Gamma and Cyber knives, the first Russian made proton accelerator “Prometheus”. Center implements such innovative technologies such as HIPEC and PIPAC, X-ray surgical methods of treatment, radionuclide and brachytherapy.
The Center has patented and is actively applying a method for preserving the reproductive functions of cancer patients using cryopreservation of genetic material.
A unique for Russia department of reconstructive plastic surgery of radiation injuries has been created.
The Center is one of the leaders in the field of Nuclear Medicine, development of Russian radiopharmaceuticals and their implementation in clinical practice. Nuclear medicine technologies in combined and complex treatment provide significant / additional therapeutic benefits for both oncological and non-oncological diseases.
The Pharmacy manufactures innovative radiopharmaceuticals based on 188Re, 177Lu and 225Ac radionuclides developed at the Center for the treatment of metastatic prostate cancer, primary and metastatic liver cancer, metastatic skeletal lesions and knee joint chronic synovitis.
It is planned to manufacture radiopharmaceuticals for the treatment of neuroendocrine malignant neoplasms, non-Hodgkin's lymphoma, etc.
The Federal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation
The Federal State Budgetary Educational Institution of Higher Education ""Russian University of Medicine"" of the Ministry of Health of the Russian Federation (hereinafter referred to as the University) is a large educational, scientific, and practical center with high scientific potential, highly qualified staff, and advanced innovative technologies. Scientific research is organized at over 100 departments and 28 laboratories within the University.
The Russian University of Medicine carries out fundamental, exploratory, and applied scientific research, as well as their experimental and clinical trials.
Main Scientific Directions:
- Import Substitution (materials, technologies, tools, equipment);
- Robotics Engineering;
- Tissue Engineering;
- Personal Medical Assistants (gadgets) and Software.
The Russian University of Medicine is an accredited medical organization within the EAEU, conducting clinical trials of medicinal products and devices.
The University employs 22 academicians of the Russian Academy of Sciences (RAS), 1 academician of the Russian Academy of Education (RAE), 18 corresponding members of the RAS, 10 honored scientists of the Russian Federation, and 15 laureates of the Government award, award of the President and the Government of Russia.
Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
The Pirogov Russian National Research Medical University of the Ministry of Health of Russia is the only medical university in Russia designated as a national research university. Its scientific activities include original research in priority scientific areas and active international collaboration with leading biomedical centers worldwide. Currently, the University is establishing a world-class preclinical translational research center.
Currently, the University has 10,000 students (bachelor's, master's, specialist degrees), 2,700 clinical residents and postgraduates; 1,650 students are citizens of foreign countries.
Total number of teaching staff: 2,508 teachers and 322 researchers, including 1,500 candidates of sciences, 700 doctors of sciences, 317 professors, 39 corresponding members of the Russian Academy of Sciences.
The University offers training in 11 specialist programs, two bachelor's programs, and 14 master's programs.
Since 2014, the University has been implementing the ""Double Degree"" program in the specialties of ""General Medicine"" and ""Biology"".
Currently, the University has 1,650 foreign citizens from more than 90 countries. Many of them demonstrate excellent academic performance.
In the field of medicine, the University comprises three leading healthcare institutions.
The Russian Gerontological Scientific and Clinical Center (190 beds).
The Scientific Research Institute of Pediatrics and Pediatric Surgery named after Academician Veltischev (370 beds).
The Russian Children's Clinical Hospital (1,025 beds).
The Federal National Medical Research Center for Hematology is the leading hematology institution in Russia.
This is a unique center for consultative and medical care for patients with diseases of the blood system. It is an alliance of 32 scientific, 94 clinical and 3 educational departments with its own production of medicines as well as Russia’s largest blood bank. Here, innovative and highly effective methods of treating hematological patients are continuously being developed.
The century-old history of the Center is associated with the names of outstanding scientists and world-class practitioners who laid the foundations of modern hematology and transfusiology.
Today, the Center is headed by a world-renowned Russian scientist, chief freelance hematologist of the Ministry of Health of Russia, Doctor of Medical Sciences, Elena Nikolaevna Parovichnikova.
Over decades of scientific and practical activity, unique experience has been accumulated in the treatment of diseases of the blood system from high-dose chemotherapy and stem cell transplantation programs to the use of immunotherapy and modern cellular technologies. The Center provides a full scope of care for hematological patients in 18 profiles from onco-hematology to neurosurgery.
Main motto- to achieve success in treatment where other specialists find a hopeless end.
Privolzhsky Research Medical University (PRMU)
Privolzhsky Research Medical University (PRMU), Nizhny Novgorod. The cohort of students enrolled in secondary and higher (specialist and master's) professional education programs, as well as residents and PhD students, is over 7.5 thousand people, foreign citizens including. This year, PRMU topped RUR World University Rankings 2024 among medical universities in Russia. PRMU has a university clinic represented by four institutes: Traumatology and Orthopedics, Rehabilitation, Pediatrics and Dentistry. The clinic treats more than 22 thousand patients from all over the country every year.
For the fourth successive year, PRMU has been on the leadership track within Priority 2030 Academic Leadership Program. We are implementing projects dedicated to agrobiotechnologies, regenerative medicine, mental health, rehabilitation and fundamental oncology in the context of the 4 strategic axes future targeted under the program. A number of developments are being applied in the country to have proved effective by now, particularly as part of import substitution.
As of today, we keep laboratory animals of all species at vivaria of our own. The country's second vivarium for non-human primates is being built. PRMU taken together with the research and clinical institutes available and the Research and Training Center for Experimental Surgery is a sought-after platform to conduct preclinical, clinical trials and advance medical (specifically postgraduate) education in Russia.
The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of Russia
The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of Russia is the largest in Europe and one of the world's largest high-tech clinical research centers providing specialized care to children with hematological, oncological and immunological diseases. It is the leading Pediatric Oncology & Hematology institution for 110 medical organizations in Russia. The Center is made up of over 150 clinical and research departments as well as other units. Here, patients with the most difficult-to-treat oncological, hematological and immunological diseases from all over Russia receive comprehensive medical care. Since 2011, 26 500 children have been treated at the Center, with over 80% of these patients ultimately cured. Healthcare professionals working at the Center are actively engaged in developing and implementing innovative methods for diagnosis, treatment and rehabilitation in Pediatric Hematology, Oncology and Immunology to be used at all Russian clinics.
ECONAD® is a Russian brand creating a new category of beverages ECONAD® was developed under the concept of changing the dietary habits of the Russian consumer.
We offer a real alternative to the existing drinks on the market, which contain coloring agents and high sugar content, provoking disease and overweight.
ECONAD® is the first and the only carbonated drink on the Russian market based on whey and extracts of useful plants.
Sechenov University
Sechenov University is the largest medical university in Russia, a leader in the fields of biomedicine, high-tech healthcare, and health preservation.
The university comprises 25 of institutes that unite education and research, 5 clinical hospitals, and 5 research centers.
Sechenov University is a world-class research university. Scientists from more than 140 leading universities around the world are engaged in joint research. Three-dimensional printing of organs and tissues, digital twins, laser surgery and gene technologies are all being developed in the largest Biomedical Science and Technology Park in Russia.
The University Clinical Center is the largest in Russia and Eastern Europe, providing high-tech medical care to patients, conducting clinical research, and creating digital solutions based on artificial intelligence. These technologies are already assisting doctors in diagnosing diseases and planning surgeries.